Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment
Davida F Kruger,1 Susan LaRue,2,3 Phil Estepa31Henry Ford Health System, Detroit, MI, USA; 2Amylin Pharmaceuticals, San Diego, CA, USA; 3AstraZeneca, San Diego, CA, USAAbstract: Injectable treatments, such as glucagon-like peptide-1 receptor agonists and insulin, are options for the pharmacologic t...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/c4101dd3e397480987d143c0013dfd54 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!